A University of Michigan spinout launched to serve the cancer research, stem cell research, & drug discovery and testing market with tools to grow cells and tissues for drug testing in a three-dimensional (3D) environment that mimics the human body, rather than the typical 2D environment, such as petri dishes, the firm appears to have closed operations in late 2017. 3D Biomatrix had provided three-dimensional (3D) cell culture solutions for drug discovery/testing, cancer research, and other life sciences research applications. Perfecta3D® products allow researchers to easily mimic tissue metabolic and proliferative gradients, capture complex cell-matrix and cell-cell interactions, conduct co-cultures, and monitor cell growth easily and regularly. The firm's 3D cell culture solutions boost life sciences research and drug discovery/testing applications by providing life-like results. Cells grown on 3D Biomatrix products have been shown to retain a much higher complexity of body response than traditional 2D cell cultures. 3D Biomatrix technologies have been featured on the cover of Analyst, and in Genetic Engineering and Biotechnology News, The Scientist, Bioscience Technology, Biocompare, Nature Nanotechnology, The Economist, Cosmetics Design Europe, Pharma Discovery and Development, Nanowerk, ScienceDaily and BiotechDaily publications.
